Background For a typical influenza infection in vivo, viral titers over time are characterized
by 1–2 days of exponential growth followed by an exponential decay. This simple dynamic …

The H275Y amino acid substitution of the neuraminidase gene is the most common
mutation conferring oseltamivir resistance in the N1 subtype of the influenza virus. Using a …

In 2007, the A/Brisbane/59/2007 (H1N1) seasonal influenza virus strain acquired the
oseltamivir-resistance mutation H275Y in its neuraminidase (NA) gene. Although previous studies …

The proportionate mortality experience of 173 decedents exposed primarily to lead arsenate
and calcium arsenate was compared with that of 1,809 decedents not exposed to those …

The 2009 pandemic H1N1 (H1N1pdm09) influenza virus is naturally susceptible to neuraminidase
(NA) inhibitors, but mutations in the NA protein can cause oseltamivir resistance. The …

Background Developing a quantitative understanding of viral kinetics is useful for determining
the pathogenesis and transmissibility of the virus, predicting the course of disease, and …

Experimentation in vitro is a vital part of the process by which the clinical and epidemiological
characteristics of a particular influenza virus strain are determined. We detail the …

Mathematical modelling has successfully been used to provide quantitative descriptions of
many viral infections, but for the Ebola virus, which requires biosafety level 4 facilities for …

Oseltamivir-resistant A/H3N2 influenza isolates with or without the E119V and I222V
neuraminidase (NA) mutations were recovered from an immunocompromised patient. Based on …

We introduce a method for the coherent acceleration of atoms trapped in an optical lattice,
using the well-known model for stimulated Raman adiabatic passage (STIRAP). Specifically, …